Gainers
- Shattuck Labs STTK stock moved upwards by 93.8% to $4.09 during Wednesday's regular session. The company's market cap stands at $173.7 million.
- Reshape Lifesciences RSLS stock rose 89.48% to $0.48. The market value of their outstanding shares is at $6.2 million.
- C4 Therapeutics CCCC shares increased by 86.32% to $4.36. The company's market cap stands at $214.8 million.
- Avalo Therapeutics AVTX shares moved upwards by 81.84% to $0.06. The company's market cap stands at $12.1 million.
- ACADIA Pharmaceuticals ACAD shares increased by 35.38% to $28.66. The company's market cap stands at $4.7 billion.
- Know Labs KNW stock increased by 26.72% to $0.73. The company's market cap stands at $59.0 million.
Losers
- OneMedNet ONMD shares decreased by 21.7% to $0.8 during Wednesday's regular session. The company's market cap stands at $25.8 million.
- Processa Pharma PCSA stock fell 19.84% to $0.65. The company's market cap stands at $16.0 million.
- Redhill Biopharma RDHL shares fell 18.94% to $1.07. The company's market cap stands at $21.0 million.
- Protagenic Therapeutics PTIX stock declined by 18.19% to $0.81. The market value of their outstanding shares is at $3.5 million.
- Silence Therapeutics SLN shares declined by 16.98% to $12.81. The company's market cap stands at $495.3 million.
- Black Diamond Therapeutic BDTX shares fell 15.26% to $2.44. The company's market cap stands at $126.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AVTXAvalo Therapeutics Inc
$8.91-%
BDTXBlack Diamond Therapeutics Inc
$2.20-0.90%
CCCCC4 Therapeutics Inc
$4.032.03%
KNWKnow Labs Inc
$0.1404-1.89%
ONMDOneMedNet Corp
$1.539.29%
PCSAProcessa Pharmaceuticals Inc
$0.8500-%
PTIXProtagenic Therapeutics Inc
$0.62824.68%
RDHLRedhill Biopharma Ltd
$6.692.92%
RSLSReshape Lifesciences Inc
$4.625.48%
SLNSilence Therapeutics PLC
$6.981.45%
STTKShattuck Labs Inc
$1.182.61%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in